{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T07:00:08Z","timestamp":1794380408657,"version":"4.9.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:00:00Z","timestamp":1779926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:00:00Z","timestamp":1779926400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003052","name":"Ministry of Trade, Industry and Energy","doi-asserted-by":"publisher","award":["RS-2025-04752969"],"award-info":[{"award-number":["RS-2025-04752969"]}],"id":[{"id":"10.13039\/501100003052","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2025-02263016"],"award-info":[{"award-number":["RS-2025-02263016"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2024-00405818"],"award-info":[{"award-number":["RS-2024-00405818"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sig Transduct Target Ther"],"DOI":"10.1038\/s41392-026-02736-y","type":"journal-article","created":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:05:26Z","timestamp":1779926726000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Combating small extracellular vesicle\u2013mediated immunological barriers in the tumor microenvironment via strategically activatable PEGylated peptides"],"prefix":"10.1038","volume":"11","author":[{"given":"Chan Ho","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyewon","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Ah","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"So Hee","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minsung","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang Hyun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sol","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung Min","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soyoung","family":"Son","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeongjin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heegun","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sohyun","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joonsuk","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiyeon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Won Ho","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min Jun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua A.","family":"Jackman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Hyung","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,28]]},"reference":[{"key":"2736_CR1","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-025-02305-x","volume":"24","author":"M Zhang","year":"2025","unstructured":"Zhang, M. et al. Advances in cancer immunotherapy: Historical perspectives, current developments, and future directions. Mol. Cancer 24, 136 (2025).","journal-title":"Mol. Cancer"},{"key":"2736_CR2","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/s41577-020-0306-5","volume":"20","author":"AD Waldman","year":"2020","unstructured":"Waldman, A. D., Fritz, J. M. & Lenardo, M. J. A guide to cancer immunotherapy: From T cell basic science to clinical practice. Nat. Rev. Immunol. 20, 651\u2013668 (2020).","journal-title":"Nat. Rev. Immunol."},{"key":"2736_CR3","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1126\/science.aar4060","volume":"359","author":"A Ribas","year":"2018","unstructured":"Ribas, A. & Wolchok, J. D. Cancer immunotherapy using checkpoint blockade. Science 359, 1350\u20131355 (2018).","journal-title":"Science"},{"key":"2736_CR4","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1038\/s41551-024-01216-4","volume":"9","author":"DK Zhang","year":"2025","unstructured":"Zhang, D. K. et al. Subcutaneous biodegradable scaffolds for restimulating the antitumour activity of pre-administered CAR-T cells. Nat. Biomed. Eng. 9, 268\u2013278 (2025).","journal-title":"Nat. Biomed. Eng."},{"key":"2736_CR5","doi-asserted-by":"publisher","first-page":"2763","DOI":"10.1021\/acs.accounts.0c00724","volume":"53","author":"XS Chen","year":"2020","unstructured":"Chen, X. S., Moon, J. J. & Cheon, J. New opportunities in cancer immunotherapy and theranostics. Acc. Chem. Res. 53, 2763\u20132764 (2020).","journal-title":"Acc. Chem. Res."},{"key":"2736_CR6","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.cell.2017.01.017","volume":"168","author":"P Sharma","year":"2017","unstructured":"Sharma, P., Hu-Lieskovan, S., Wargo, J. A. & Ribas, A. Primary, adaptive, and acquired resistance to cancer immunotherapy. Cell 168, 707\u2013723 (2017).","journal-title":"Cell"},{"key":"2736_CR7","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.1056\/NEJMoa1200690","volume":"366","author":"SL Topalian","year":"2012","unstructured":"Topalian, S. L. et al. Safety, activity, and immune correlates of anti\u2013PD-1 antibody in cancer. N. Engl. J. Med. 366, 2443\u20132454 (2012).","journal-title":"N. Engl. J. Med."},{"key":"2736_CR8","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1038\/s41563-024-01961-6","volume":"23","author":"N Gong","year":"2024","unstructured":"Gong, N. et al. Tumour-derived small extracellular vesicles act as a barrier to therapeutic nanoparticle delivery. Nat. Mater. 23, 1736\u20131747 (2024).","journal-title":"Nat. Mater."},{"key":"2736_CR9","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1172\/JCI81136","volume":"126","author":"TL Whiteside","year":"2016","unstructured":"Whiteside, T. L. Exosomes and tumor-mediated immune suppression. J. Clin. Invest. 126, 1216\u20131223 (2016).","journal-title":"J. Clin. Invest."},{"key":"2736_CR10","doi-asserted-by":"crossref","unstructured":"Kalluri, R. & LeBleu, V. S. The biology, function, and biomedical applications of exosomes. Science 367, eaau6977 (2020).","DOI":"10.1126\/science.aau6977"},{"key":"2736_CR11","doi-asserted-by":"publisher","first-page":"e12404","DOI":"10.1002\/jev2.12404","volume":"13","author":"JA Welsh","year":"2024","unstructured":"Welsh, J. A. et al. Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches. J. Extracell. Vesicles 13, e12404 (2024).","journal-title":"J. Extracell. Vesicles"},{"key":"2736_CR12","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1038\/s41586-018-0392-8","volume":"560","author":"G Chen","year":"2018","unstructured":"Chen, G. et al. Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response. Nature 560, 382\u2013386 (2018).","journal-title":"Nature"},{"key":"2736_CR13","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1038\/ncb3169","volume":"17","author":"B Costa-Silva","year":"2015","unstructured":"Costa-Silva, B. et al. Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver. Nat. Cell Biol. 17, 816\u2013826 (2015).","journal-title":"Nat. Cell Biol."},{"key":"2736_CR14","doi-asserted-by":"publisher","first-page":"3748","DOI":"10.1182\/blood-2014-05-576116","volume":"124","author":"T Umezu","year":"2014","unstructured":"Umezu, T. et al. Exosomal miR-135b shed from hypoxic multiple myeloma cells enhances angiogenesis by targeting factor-inhibiting HIF-1. Blood 124, 3748\u20133757 (2014).","journal-title":"Blood"},{"key":"2736_CR15","doi-asserted-by":"publisher","first-page":"123733","DOI":"10.1016\/j.biomaterials.2025.123733","volume":"327","author":"H Ko","year":"2026","unstructured":"Ko, H., Kim, C. H., Son, S., Shin, J. M. & Park, J. H. Unlocking the therapeutic potential of tumor-derived small extracellular vesicles in cancer immunotherapy: A multifaceted approach. Biomaterials 327, 123733 (2026).","journal-title":"Biomaterials"},{"key":"2736_CR16","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1038\/s12276-022-00856-3","volume":"54","author":"Y Li","year":"2022","unstructured":"Li, Y. et al. Targeted inhibition of tumor-derived exosomes as a novel therapeutic option for cancer. Exp. Mol. Med. 54, 1379\u20131389 (2022).","journal-title":"Exp. Mol. Med."},{"key":"2736_CR17","doi-asserted-by":"publisher","first-page":"2790","DOI":"10.1158\/0008-5472.CAN-22-2220","volume":"83","author":"W Zhong","year":"2023","unstructured":"Zhong, W. et al. Tumor-derived small extracellular vesicles inhibit the efficacy of CAR T cells against solid tumors. Cancer Res. 83, 2790\u20132806 (2023).","journal-title":"Cancer Res"},{"key":"2736_CR18","doi-asserted-by":"publisher","first-page":"2400762","DOI":"10.1002\/adma.202400762","volume":"36","author":"J Wu","year":"2024","unstructured":"Wu, J. et al. Exosome-inhibiting polymeric sonosensitizer for tumor-specific sonodynamic immunotherapy. Adv. Mater. 36, 2400762 (2024).","journal-title":"Adv. Mater."},{"key":"2736_CR19","doi-asserted-by":"publisher","first-page":"2103245","DOI":"10.1002\/advs.202103245","volume":"9","author":"JM Shin","year":"2022","unstructured":"Shin, J. M. et al. Sulfisoxazole elicits robust antitumour immune response along with immune checkpoint therapy by inhibiting exosomal PD-L1. Adv. Sci. 9, 2103245 (2022).","journal-title":"Adv. Sci."},{"key":"2736_CR20","doi-asserted-by":"publisher","first-page":"113569","DOI":"10.1016\/j.jconrel.2025.02.065","volume":"381","author":"J Kim","year":"2025","unstructured":"Kim, J. et al. Dual-delivery of exosome inhibitor and immune-activating gene via lipid nano-assemblies for tumor immune evasion inhibition. J. Control. Release 381, 113569 (2025).","journal-title":"J. Control. Release"},{"key":"2736_CR21","doi-asserted-by":"publisher","first-page":"121058","DOI":"10.1016\/j.biomaterials.2021.121058","volume":"276","author":"S Son","year":"2021","unstructured":"Son, S. et al. Repurposing macitentan with nanoparticle modulates tumor microenvironment to potentiate immune checkpoint blockade. Biomaterials 276, 121058 (2021).","journal-title":"Biomaterials"},{"key":"2736_CR22","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1038\/s41563-023-01515-2","volume":"22","author":"S Shin","year":"2023","unstructured":"Shin, S. et al. Curvature-sensing peptide inhibits tumour-derived exosomes for enhanced cancer immunotherapy. Nat. Mater. 22, 656\u2013665 (2023).","journal-title":"Nat. Mater."},{"key":"2736_CR23","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1038\/s41563-018-0194-2","volume":"17","author":"JA Jackman","year":"2018","unstructured":"Jackman, J. A. et al. Therapeutic treatment of Zika virus infection using a brain-penetrating antiviral peptide. Nat. Mater. 17, 971\u2013977 (2018).","journal-title":"Nat. Mater."},{"key":"2736_CR24","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.cell.2019.02.016","volume":"177","author":"M Poggio","year":"2019","unstructured":"Poggio, M. et al. Suppression of exosomal PD-L1 induces systemic anti-tumor immunity and memory. Cell 177, 414\u2013427.e413 (2019).","journal-title":"Cell"},{"key":"2736_CR25","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1038\/nbt.3330","volume":"33","author":"E Blanco","year":"2015","unstructured":"Blanco, E., Shen, H. & Ferrari, M. Principles of nanoparticle design for overcoming biological barriers to drug delivery. Nat. Biotechnol. 33, 941\u2013951 (2015).","journal-title":"Nat. Biotechnol."},{"key":"2736_CR26","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1002\/anie.202006372","volume":"60","author":"M Cavaco","year":"2021","unstructured":"Cavaco, M., Andreu, D. & Castanho, M. A. The challenge of peptide proteolytic stability studies: scarce data, difficult readability, and the need for harmonization. Angew. Chem. Int. Ed. 60, 1686\u20131688 (2021).","journal-title":"Angew. Chem. Int. Ed."},{"key":"2736_CR27","doi-asserted-by":"publisher","first-page":"e202203942","DOI":"10.1002\/anie.202203942","volume":"61","author":"D Braatz","year":"2022","unstructured":"Braatz, D. et al. Chemical Approaches to Synthetic Drug Delivery Systems for Systemic Applications. Angew. Chem. Int. Ed. 61, e202203942 (2022).","journal-title":"Angew. Chem. Int. Ed."},{"key":"2736_CR28","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/nrd1033","volume":"2","author":"JM Harris","year":"2003","unstructured":"Harris, J. M. & Chess, R. B. Effect of pegylation on pharmaceuticals. Nat. Rev. Drug Discov. 2, 214\u2013221 (2003).","journal-title":"Nat. Rev. Drug Discov."},{"key":"2736_CR29","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1021\/bc000082g","volume":"12","author":"P Bailon","year":"2001","unstructured":"Bailon, P. et al. Rational design of a potent, long-lasting form of interferon:\u2009A 40 kDa branched polyethylene glycol-conjugated interferon \u03b1-2a for the treatment of Hepatitis C. Bioconjugate Chem. 12, 195\u2013202 (2001).","journal-title":"Bioconjugate Chem."},{"key":"2736_CR30","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1016\/j.jcis.2024.02.018","volume":"663","author":"Z-R Yang","year":"2024","unstructured":"Yang, Z.-R. et al. Acidity-activated aggregation and accumulation of self-complementary zwitterionic peptide-decorated gold nanoparticles for photothermal biofilm eradication. J. Colloid Interface Sci. 663, 1074\u20131086 (2024).","journal-title":"J. Colloid Interface Sci."},{"key":"2736_CR31","doi-asserted-by":"publisher","first-page":"e003217","DOI":"10.1136\/jitc-2021-003217","volume":"9","author":"M Feiya","year":"2021","unstructured":"Feiya, M., Jensen, V., Grace, L., Yuqi, W. & Guangyong, P. Emerging role of tumor-derived extracellular vesicles in T cell suppression and dysfunction in the tumor microenvironment. J. Immunother. Cancer 9, e003217 (2021).","journal-title":"J. Immunother. Cancer"},{"key":"2736_CR32","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1038\/sj.bjc.6602316","volume":"92","author":"DD Taylor","year":"2005","unstructured":"Taylor, D. D. & Ger\u00e7el-Taylor, C. Tumour-derived exosomes and their role in cancer-associated T-cell signalling defects. Br. J. Cancer 92, 305\u2013311 (2005).","journal-title":"Br. J. Cancer"},{"key":"2736_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-07191-7","volume":"15","author":"T Liu","year":"2024","unstructured":"Liu, T. et al. PD-L2 of tumor-derived exosomes mediates the immune escape of cancer cells via the impaired T cell function. Cell Death Dis. 15, 800 (2024).","journal-title":"Cell Death Dis."},{"key":"2736_CR34","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s40425-017-0269-7","volume":"5","author":"TM Brian","year":"2017","unstructured":"Brian, T. M., Lukas, W. P., Marcela, D.-M. & Brian, R. G. Tumor-derived exosomes induce CD8+ T cell suppressors. J. Immunother. Cancer 5, 65 (2017).","journal-title":"J. Immunother. Cancer"},{"key":"2736_CR35","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1158\/1541-7786.MCR-17-0784","volume":"16","author":"C Ringuette Goulet","year":"2018","unstructured":"Ringuette Goulet, C. et al. Exosomes induce fibroblast differentiation into cancer-associated fibroblasts through TGF\u03b2 signaling. Mol. Cancer Res. 16, 1196\u20131204 (2018).","journal-title":"Mol. Cancer Res."},{"key":"2736_CR36","doi-asserted-by":"publisher","first-page":"1800148","DOI":"10.1002\/pmic.201800148","volume":"19","author":"A Rai","year":"2019","unstructured":"Rai, A. et al. Exosomes derived from human primary and metastatic colorectal cancer cells contribute to functional heterogeneity of activated fibroblasts by reprogramming their proteome. Proteomics 19, 1800148 (2019).","journal-title":"Proteomics"},{"key":"2736_CR37","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.actbio.2018.07.001","volume":"76","author":"JH Yeon","year":"2018","unstructured":"Yeon, J. H. et al. Cancer-derived exosomes trigger endothelial to mesenchymal transition followed by the induction of cancer-associated fibroblasts. Acta Biomater. 76, 146\u2013153 (2018).","journal-title":"Acta Biomater."},{"key":"2736_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-023-01408-6","volume":"22","author":"K H\u00e1n\u011blov\u00e1","year":"2024","unstructured":"H\u00e1n\u011blov\u00e1, K., Raudensk\u00e1, M., Masa\u0159\u00edk, M. & Balvan, J. Protein cargo in extracellular vesicles as the key mediator in the progression of cancer. Cell Commun. Signal. 22, 25 (2024).","journal-title":"Cell Commun. Signal."},{"key":"2736_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-01932-0","volume":"23","author":"C Zhang","year":"2024","unstructured":"Zhang, C. et al. Tumor-derived small extracellular vesicles in cancer invasion and metastasis: molecular mechanisms, and clinical significance. Mol. Cancer 23, 18 (2024).","journal-title":"Mol. Cancer"},{"key":"2736_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-25990-w","volume":"12","author":"G Wang","year":"2021","unstructured":"Wang, G. et al. A nanounit strategy reverses immune suppression of exosomal PD-L1 and is associated with enhanced ferroptosis. Nat. Commun. 12, 5733 (2021).","journal-title":"Nat. Commun."},{"key":"2736_CR41","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/ncb2000","volume":"12","author":"M Ostrowski","year":"2010","unstructured":"Ostrowski, M. et al. Rab27a and Rab27b control different steps of the exosome secretion pathway. Nat. Cell Biol. 12, 19\u201330 (2010).","journal-title":"Nat. Cell Biol."},{"key":"2736_CR42","doi-asserted-by":"publisher","first-page":"754","DOI":"10.3390\/cells13090754","volume":"13","author":"S Shahi","year":"2024","unstructured":"Shahi, S., Kang, T. & Fonseka, P. Extracellular vesicles in pathophysiology: A prudent target that requires careful consideration. Cells 13, 754 (2024).","journal-title":"Cells"},{"key":"2736_CR43","doi-asserted-by":"publisher","first-page":"26858","DOI":"10.1021\/acsnano.4c08117","volume":"18","author":"S Qin","year":"2024","unstructured":"Qin, S. et al. Spatiotemporal delivery of dual nanobodies by engineered probiotics to reverse tumor immunosuppression via targeting tumor-derived exosomes. ACS Nano 18, 26858\u201326871 (2024).","journal-title":"ACS Nano"},{"key":"2736_CR44","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1002\/hep.30607","volume":"70","author":"J Liu","year":"2019","unstructured":"Liu, J. et al. Endoplasmic reticulum stress causes liver cancer cells to release exosomal miR-23a-3p and up-regulate programmed death ligand 1 expression in macrophages. Hepatology 70, 241\u2013258 (2019).","journal-title":"Hepatology"},{"key":"2736_CR45","doi-asserted-by":"publisher","first-page":"5238","DOI":"10.1158\/0008-5472.CAN-04-3804","volume":"65","author":"R Gastpar","year":"2005","unstructured":"Gastpar, R. et al. Heat shock protein 70 surface-positive tumor exosomes stimulate migratory and cytolytic activity of natural killer cells. Cancer Res. 65, 5238\u20135247 (2005).","journal-title":"Cancer Res."},{"key":"2736_CR46","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1158\/2326-6066.CIR-17-0581","volume":"6","author":"JM Diamond","year":"2018","unstructured":"Diamond, J. M. et al. Exosomes shuttle TREX1-sensitive IFN-stimulatory dsDNA from irradiated cancer cells to DCs. Cancer Immunol. Res. 6, 910\u2013920 (2018).","journal-title":"Cancer Immunol. Res."},{"key":"2736_CR47","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1002\/hep.28549","volume":"64","author":"Q Rao","year":"2016","unstructured":"Rao, Q. et al. Tumor-derived exosomes elicit tumor suppression in murine hepatocellular carcinoma models and humans in vitro. Hepatology 64, 456\u2013472 (2016).","journal-title":"Hepatology"},{"key":"2736_CR48","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1248\/bpb.b12-00276","volume":"35","author":"T Shimizu","year":"2012","unstructured":"Shimizu, T. et al. Intravenous administration of polyethylene glycol-coated (PEGylated) proteins and PEGylated adenovirus elicits an anti-PEG immunoglobulin M response. Biol. Pharm. Bull. 35, 1336\u20131342 (2012).","journal-title":"Biol. Pharm. Bull."},{"key":"2736_CR49","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1021\/acs.bioconjchem.5c00123","volume":"36","author":"H Chen","year":"2025","unstructured":"Chen, H., Dong, Y., Shi, F. & Li, F. Modulation of membrane-disruptive activity of melittin via N-and C-terminal PEGylation strategies. Bioconjugate Chem. 36, 1438\u20131447 (2025).","journal-title":"Bioconjugate Chem."},{"key":"2736_CR50","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.tcb.2024.08.008","volume":"35","author":"X Dou","year":"2025","unstructured":"Dou, X., Feng, C., Li, J., Jiang, E. & Shang, Z. Extracellular vesicle-mediated crosstalk in tumor microenvironment dominates tumor fate. Trends Cell Biol. 35, 230\u2013247 (2025).","journal-title":"Trends Cell Biol."},{"key":"2736_CR51","doi-asserted-by":"publisher","first-page":"2904","DOI":"10.1158\/0008-5472.CAN-21-4141","volume":"82","author":"L Jenkins","year":"2022","unstructured":"Jenkins, L. et al. Cancer-associated fibroblasts suppress CD8+ T-cell infiltration and confer resistance to immune-checkpoint blockade. Cancer Res. 82, 2904\u20132917 (2022).","journal-title":"Cancer Res."},{"key":"2736_CR52","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.trecan.2024.04.003","volume":"10","author":"M Julve","year":"2024","unstructured":"Julve, M., Lythgoe, M. P., Larkin, J. & Furness, A. J. S. Lifileucel: The first cellular therapy approved for solid tumours. Trends Cancer 10, 475\u2013477 (2024).","journal-title":"Trends Cancer"},{"key":"2736_CR53","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-56527-0","volume":"16","author":"V Albarr\u00e1n-Fern\u00e1ndez","year":"2025","unstructured":"Albarr\u00e1n-Fern\u00e1ndez, V. et al. Unlocking the potential of engineered immune cell therapy for solid tumors. Nat. Commun. 16, 1144 (2025).","journal-title":"Nat. Commun."},{"key":"2736_CR54","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1158\/1535-7163.MCT-23-0310","volume":"23","author":"A Doug\u00e9","year":"2024","unstructured":"Doug\u00e9, A., El Ghazzi, N., Lemal, R. & Rouzaire, P. Adoptive T cell therapy in solid tumors: State-of-the art, current challenges, and upcoming improvements. Mol. Cancer Ther. 23, 272\u2013284 (2024).","journal-title":"Mol. Cancer Ther."},{"key":"2736_CR55","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1038\/nchembio.2416","volume":"13","author":"CB Rosen","year":"2017","unstructured":"Rosen, C. B. & Francis, M. B. Targeting the N terminus for site-selective protein modification. Nat. Chem. Biol. 13, 697\u2013705 (2017).","journal-title":"Nat. Chem. Biol."},{"key":"2736_CR56","doi-asserted-by":"publisher","first-page":"123165","DOI":"10.1016\/j.biomaterials.2025.123165","volume":"318","author":"SH Kim","year":"2025","unstructured":"Kim, S. H. et al. Glycoengineered stem cell-derived extracellular vesicles for targeted therapy of acute kidney injury. Biomaterials 318, 123165 (2025).","journal-title":"Biomaterials"},{"key":"2736_CR57","doi-asserted-by":"crossref","unstructured":"Jones, D. S. et al. Cell surface\u2013tethered IL-12 repolarizes the tumor immune microenvironment to enhance the efficacy of adoptive T cell therapy. Sci. Adv. 8, eabi8075 (2022).","DOI":"10.1126\/sciadv.abi8075"}],"container-title":["Signal Transduction and Targeted Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02736-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02736-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02736-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:05:27Z","timestamp":1779926727000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02736-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,28]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2736"],"URL":"https:\/\/doi.org\/10.1038\/s41392-026-02736-y","relation":{},"ISSN":["2059-3635"],"issn-type":[{"value":"2059-3635","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,28]]},"assertion":[{"value":"26 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"C.H.K., H.K., S.S., S.S., J.A.J., and J.H.P. are named as inventors on US patent application no. 17\/818,874 filed by the Sungkyunkwan University Research & Business Foundation. The remaining authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"200"}}